We are aware of an issue causing the title of some ARTG entries to disappear. We are investigating as a priority and hope to have this resolved as soon as possible.
DEXAMETHASONE VIATRIS dexamethasone phosphate (as dexamethasone sodium phosphate) 8 mg/2 mL solution for injection vial, Alphapharm Pty Ltd, CON-1064
Product name
DEXAMETHASONE VIATRIS dexamethasone phosphate (as dexamethasone sodium phosphate) 8 mg/2 mL solution for injection vial
Sponsor name
Alphapharm Pty Ltd
Consent start
Consent no.
CON-1064
Duration
The consent is effective from 12 January 2023 until 30 June 2023.
Standard
The product does not meet the pH requirements of British Pharmacopoeia
Non-compliance with standard
The product does not meet the pH requirements in the monograph
Conditions imposed
1. A ‘Dear Healthcare Provider’ letter identical to that provided to the
Therapeutic Goods Administration on 15 July 2022 will be supplied with each
affected batch
2. The TGA must be inform immediately by writing to the decision delegate if any
batch of the product(s) is analysed and the results obtained for pH are greater
than or equal to pH 9.0.
Therapeutic product type
Prescription medicines